Under the terms of the agreement, Comercial Uni2 has exclusive rights to sell and distribute US-based Oxygen Biotherapeutics' Dermacyte skin care products throughout Mexico.
Datamonitor Research shows that the market for skin care in Mexico increased at a compound annual growth rate of 5.2 percent between 2004 and 2009.
"Oxygen-based skin care treatments are at the cutting edge of today's cosmetics. Dermacyte skin care lotions provide a unique value proposition in a growing Mexican cosmetics market," said Felix Bautista, owner of Comercial Uni2.
"Mexico is a growing, dynamic cosmetic market and the gateway to Central America," said Chris Stern, Chairman and Chief Executive Officer of Oxygen Biotherapeutics. "We are pleased to make our product available to this important market."